The costimulatory molecule 4-1BB and its ligand 4-1BBL can control adaptive immunity, but here we show that their interaction also suppressed myelopoiesis. We found that 4-1BBL was expressed on hematopoietic stem cells, differentiating common myeloid progenitors and granulocyte-macrophage progenitors, and 4-1BB was inducible on activated myeloid progenitors. Steady-state numbers of granulocyte-macrophage progenitors, myeloid-lineage cells and mature dendritic cells were higher in 4-1BB-and 4-1BBL-deficient mice, indicative of a negative function, and we confirmed that result with bone marrow chimeras and in vitro, where the absence of interactions between 4-1BB and 4-1BBL led to enhanced differentiation into dendritic cell lineages. The regulatory activity was mediated by 4-1BBL, with binding by 4-1BB inhibiting differentiation of myeloid progenitors. Thus, 4-1BB and 4-1BBL have a previously unknown function in limiting myelopoiesis and the development of dendritic cells.
The receptor 4-1BB (also called CD137 and TNFRSF9), a member of the tumor necrosis factor (TNF) receptor 'superfamily' , was first identified as an inducible costimulatory molecule on activated T cells 1 . The ligand of 4-1BB (4-1BBL; also called CD137L or TNFSF9), also a TNF 'superfamily' member, was subsequently found to be expressed on activated antigen-presenting cells such as B cells, macrophages and dendritic cells (DCs) 2, 3 . The interaction of 4-1BB with 4-1BBL regulates immunity and has been proposed to 'preferentially' control T cell responses, on the basis of studies of various mouse models of cancer, infectious disease and autoimmune disease 4, 5 . Much of the early literature on 4-1BB-4-1BBL interactions was derived from studies with agonist antibodies to 4-1BB and 4-1BBL-deficient (Tnfsf9 -/-) mice 5 , which demonstrated a positive regulatory function in T cell priming 6, 7 and suggested that signals from 4-1BB costimulate T cells. In contrast, subsequent data have suggested that the biology of 4-1BB is much more complex than simply positive regulation of T cell immunity. Splenocytes from 4-1BB-deficient (Tnfrsf9 -/-) mice show hyperproliferation in response to mitogens 8 , and adoptive-transfer experiments with antigen-specific T cells that cannot express 4-1BB have shown enhanced rather than suppressed initial CD4 + and CD8 + T cell responses in vivo 9, 10 . Furthermore, other research with agonist antibody to 4-1BB (anti-4-1BB) has demonstrated suppression of inflammation and autoimmunity in many settings 11 ; such data might be explained by the promotion of regulatory mechanisms or a true suppressive activity.
Although originally thought to be exclusive to T cells, expression of 4-1BB in vivo might be very broad. It has been found on natural killer (NK) cells 12 and is also inducible on certain myeloid-lineage cells such as DCs [13] [14] [15] , granulocytes 16 and mast cells 17 . Furthermore, DCs and mast cells express both 4-1BB and 4-1BBL after activation, possibly at the same time, and crosslinking of 4-1BB on these cells can regulate cellular function 14, 17 . Tnfrsf9 -/-and Tnfsf9 -/-mice show no apparent defects in the development of T lymphocytes and B lymphocytes and lymphoid organs 8, 18 , whereas transgenic expression of 4-1BBL under control of the promoter of the gene encoding major histocompatibility complex (MHC) class II results in selective depletion of B cells and population expansion of Mac-1 + cells 19 . Notably, Tnfrsf9 -/-cells from spleen, blood and bone marrow show enhanced myeloid colony-forming potential in vitro 8 . Collectively, these results suggest the possibility that 4-1BB-4-1BBL interactions are involved in cellular development and differentiation, particularly in the myeloid lineage. Here we report that 4-1BBL was expressed on hematopoietic stem cells (HSCs) and myeloid progenitor cells, including common myeloid progenitors (CMPs) and granulocyte-macrophage progenitors (GMPs), as well as differentiating myeloid-lineage cells, and 4-1BB was inducible on those last cells by cytokines that regulate myelopoiesis. We found that the interaction of these molecules functionally suppressed early steps of myelopoiesis and limited the differentiation of monocytes and DCs, including conventional DC (cDC) and plasmacytoid DC (pDC) lineages. Our results define a previously unidentified regulatory function for the 4-1BB-4-1BBL interaction in the development of myeloid-lineage cells and DCs.
RESULTS

Expression of 4-1BBL on HSCs and progenitors
We assessed the expression of 4-1BB and 4-1BBL in the bone marrow. The characterization of bone marrow cells has allowed identification of the stepwise development of HSCs and progenitors [20] [21] [22] . Bone marrow cells were grouped in several populations (Fig. 1) . These included LSK cells (lineage-negative (Lin -) Sca-1 + c-Kit hi interleukin 7 receptor a-negative (IL-7Ra -)), encompassing long-term and shortterm HSCs, and multipotent progenitors (MPPs); myeloid progenitors (Lin -Sca-1 -c-Kit hi IL-7Ra -), including CMPs, GMPs and megakaryocyte-erythrocyte progenitors (MEPs); and common lymphoid progenitors (CLPs; Lin -Sca-1 lo c-Kit lo IL-7Ra + ). Membrane expression of 4-1BBL is regulated after binding to 4-1BB, a common phenomenon of the TNF family, probably through cleavage from the cell membrane; therefore, we analyzed cells from both wild-type and Tnfrsf9 -/-mice (Fig. 1) . We detected 4-1BBL on long-term and short-term HSCs and MPPs (Fig. 1a) , as well as CLPs (Fig. 1b) and CMPs and GMPs, but not on MEPs (Fig. 1c) . After differentiation, 4-1BBL expression was lost on mature cells of those specific lineages (B cells, T cells, granulocytes and monocytes) in the bone marrow and periphery ( Supplementary Fig. 1 online and data not shown). Thus, 4-1BBL is available on HSCs and progenitor cells in the bone marrow, which suggests a possible function in early steps of hematopoiesis.
We found 4-1BBL on HSCs and MPPs regardless of whether cells were derived from wild-type or Tnfrsf9 -/-mice, but expression on CLPs, CMPs and GMPs was confined mainly to cells lacking 4-1BB (Fig. 1) . This result indicates that 4-1BBL on CLPs, CMPs and GMPs is being actively engaged in situ by 4-1BB in the bone marrow, but that 4-1BBL on HSCs and MPPs might not be active in steady-state conditions. In line with the idea that 4-1BB and 4-1BBL are involved in hematopoiesis, analysis of steady-state numbers of stem cells and progenitor cells in the bone marrow of adult 4-1BB-or 4-1BBL-deficient mice showed enhanced percentages of GMPs and CD11b + myeloid-lineage cells (Fig. 2a) . That finding prompted the unexpected idea that these molecules have a suppressive or rate-limiting function in early steps of myelopoiesis. Further supporting that conclusion, we found higher percentages of CD11c hi DCs in the spleen in the absence of 4-1BB-4-1BBL interactions (Fig. 2b) , reflected mainly by more CD4 + CD8 -cDCs, although we found statistically significant differences in the numbers of all DC subsets, including pDCs (Fig. 2c) . These data suggest that 4-1BBL on CMPs or GMPs, or on differentiating progeny of those cells, through engagement of 4-1BB, represents a rate-limiting step in myelopoiesis leading to the differentiation of DCs that accumulate in lymphoid organs. Although CLPs expressed 4-1BBL, we found no difference in their steady-state numbers (Fig. 2a) or in peripheral B lineage cells (follicular, marginal zone, B-1a; Fig. 2c ) or the T cell lineage (conventional T cells, regulatory T cells and NKT cells; data not shown) in Tnfrsf9 -/-mice, which indicates that 4-1BBL is not important in CLPs in normal conditions of lymphopoiesis.
Limitation of myelopoiesis by 4-1BB on myeloid progenitors
The sources of 4-1BB then became of interest. We did not detect 4-1BB on any stem cell or progenitor population in the bone marrow in situ, except for a small percentage (2-3%) of CLPs (Fig. 1b) . Bone marrow NK cells and some CD8 + T cells expressed 4-1BB (Supplementary Fig. 1 and data not shown), which probably reflected peripherally activated cells trafficking in and out of this organ. These cells therefore might represent one potential source of 4-1BB to ligate 4-1BBL.
Another potential source might be a differentiating progenitor cell that participates in cell-intrinsic or cell-extrinsic regulation, and the lack of detection of 4-1BB in the bone marrow in situ might reflect very transient expression induced by cytokines that promote myelopoiesis. To test that idea, we cultured purified total myeloid progenitors (Lin -Sca-1 -c-Kit hi IL-7Ra -; Fig. 3a ) with a cytokine 'cocktail' known to support in vitro myelopoiesis (stem cell factor, IL-11, IL-3, thrombopoietin and granulocyte-monocyte colony-stimulating factor (GM-CSF)) 23, 24 . Most myeloid progenitors downregulated c-Kit expression to intermediate amounts after 1 d and underwent stepwise differentiation into myeloid-lineage cells (Lin + c-Kit -) through a transitional cell population (Lin -c-Kit int and Lin + c-Kit int ; Fig. 3a and Supplementary Fig. 2a online) . We also found a subpopulation of cells that retained myeloid progenitor-like markers, in that they were Lin -c-Kit hi , which we visualized from days 2-6 while they maintained their surface phenotype ( Fig. 3a and Supplementary  Fig. 2a ). Further characterization of Lin + cells showed that 95% were CD11b + (data not shown) and some gained expression of F4/80 or Gr-1 at day 4 ( Fig. 3b) , which indicated their differentiation into the monocyte and granulocyte lineages. Most Lin -c-Kit hi cells expressed the immunoglobulin receptor FceRIa, Sca-1 and integrin a 4 b 7 , which suggested that these cells were differentiating precursors of mature mast cells 25 (Fig. 3b) .
We found that 4-1BB was induced on subpopulations of Lin + cells, increasing from day 3 to day 6 ( Fig. 3c and Supplementary Fig. 2b,c) . Additionally, 4-1BB was prominent on the surface of Lin -c-Kit hi cells at day 3, but its expression was more transient. Lin + cells that expressed 4-1BB were CD11b hi c-Kit int and most expressed F4/80, with only 3-5% being Gr-1 + (Fig. 3d) ; therefore, they represented myeloid progenitor cells differentiating into the monocyte lineage. Lin -c-Kit hi cells that expressed 4-1BB were FceRIa + and FceRIa -and had low surface expression of Sca-1 and integrin a 4 b 7 (Fig. 3d) , which confirmed that 4-1BB was also inducible on differentiating mast cell precursors. We found that 4-1BBL was expressed on the Lin -c-Kit int population throughout culture but was downregulated almost completely on Lin + c-Kit int cells ( Fig. 3c and Supplementary Fig. 2b,c) . When cells further differentiated into Lin + c-Kit -cells, we again found 4-1BBL but at lower abundance. We noted that 4-1BBL was also present on the surface of Lin -c-Kit hi cells throughout culture. In most cases, 4-1BBL expression was higher on 4-1BB-deficient cells, which suggested that active ligation with 4-1BB was occurring in these cultures. Notably, when we cultured myeloid progenitors with various cytokine combinations that can stimulate proliferation but less differentiation, we found that both Lin -c-Kit hi and myeloid-lineage cells lacked 4-1BB, and its expression depended on GM-CSF (Supplementary Fig. 3 online) . In contrast, there was 4-1BBL on the Lin -c-Kit int cells regardless of cytokines added in culture (data not shown).
Thus, 4-1BB expressed on differentiating myeloid-lineage cells and mast cells precursors, along with 4-1BB on bone marrow-resident CD8 + T cells and NK cells, could partner with 4-1BBL on CMPs, GMPs and/or cells derived from those progenitors differentiating into the monocyte or DC lineage. In support of the idea that the source of 4-1BB in vivo is probably differentiating myeloid and mast cell precursors and confirming the proposal of a regulatory rather than stimulatory function, we found that more Lin -c-Kit hi mast cell precursors ( Fig. 4a) and Lin + c-Kit -myeloid-lineage cells ( Fig. 4b-d ) were generated in vitro over time when purified Tnfrsf9 -/-or Tnfsf9 -/-myeloid progenitors were differentiated in culture. To further explore this regulatory event, we added an agonistic antibody to 4-1BB 26 , and a fusion protein of 4-1BB and immunoglobulin (4-1BB-Ig) delivered in plate-bound form to crosslink 4-1BBL, to myeloid progenitor cultures. Agonistic stimulation of 4-1BB did not have much of an effect on myelopoiesis. In contrast, 4-1BB-Ig resulted in much less accumulation of Tnfrsf9 -/-myeloid-lineage cells, to numbers noted
LT with wild-type cells (Fig. 4c) , but could not reverse the outgrowth of Tnfsf9 -/-myeloid progenitors (Fig. 4d) . Thus, the binding of 4-1BB to 4-1BBL on differentiating myeloid progenitors (CMPs and GMPs) and/or myeloid-lineage cells has a suppressive effect on the accumulation of myeloid-lineage cells brought about by inhibitory signaling through 4-1BBL. This action is analogous to published results showing that crosslinking of 4-1BBL suppresses the differentiation and/or outgrowth of osteoclasts from bone marrow macrophages in response to RANKL, the ligand for the receptor-activator of transcription factor NF-kB 27, 28 .
Negative regulation of myelopoiesis and DCs by 4-1BB
To further show a suppressive function for 4-1BB-4-1BBL interactions in myelopoiesis in vivo, we did competitive repopulation experiments. We depleted wild-type (CD45.1 + ) and Tnfrsf9 -/-(CD45.2 + ) bone marrow of B cells and T cells and transferred 1:1 mixtures of the bone marrow cells into lethally irradiated recipient mice (CD45.1 + ). At 8 weeks after reconstitution, the main population of blood monocytes was CD45.2 + cells originating from Tnfrsf9 -/-bone marrow (Fig. 5a ). This population included both Gr-1 + and Gr-1 -subsets, which are suggested to have the alternative potential to differentiate into DCs and macrophages 29 . In parallel, development of blood granulocytes was favored in the absence of 4-1BB. Analysis of bone marrow, in which initial myelopoiesis takes place, leading to output into the blood, further demonstrated a greater proportion of CD11b + Gr-1 + cells of Tnfrsf9 -/-origin (Fig. 5b) .
In support of the idea that 4-1BB limits the homeostasis of myeloid-lineage cells, analysis of splenocytes showed that many more DCs of both the conventional lineage (cDCs; CD11c hi and high MHC class II expression, I-A/I-E hi ) and plasmacytoid lineage (pDCs; CD11c lo PDCA-1 + I-A/I-E int ) originated from Tnfrsf9 -/-bone marrow (Fig. 5c,d) . We obtained similar data with peripheral lymph nodes (data not shown). The lack of 4-1BB favored the development of CD4 + CD8 -cells, with a higher percentage in the cDC population (Fig. 5c) , although both CD4 + CD8 -and CD4 -CD8 + populations were greater in number (Fig. 5d) . We found no difference in maturation of the DCs on the basis of expression of CD80, CD86, CD40 and MHC class II molecules (data not shown). This finding replicates and confirms the steady-state phenotype of 4-1BB-deficient mice (Fig. 2c) , although the suppressive effect was greater, probably reflective of the higher rate of hematopoiesis in the bone marrow chimeras. In lymphoid organs, similar numbers of granulocytes (CD11b + Gr-1 hi ), NK cells (CD3 -NK1.1 + DX5 + ), and CD4 + and CD8 + T cells were derived from wild-type and Tnfrsf9 -/-bone marrow. Almost the same pattern of cell development was present in recombination-activating gene 1-deficient (Rag1 -/-) recipients of unseparated bone marrow cells ( Supplementary Fig. 4a online) and in congenic mice at different time points ( Supplementary Fig. 4b and data not shown) . Thus, 4-1BB limits the development of DCs that accumulate in lymphoid organs in steady-state conditions and in conditions of considerable myelopoiesis. Notably, we also found more B cells of Tnfrsf9 -/-origin in the wild-type and Rag1 -/-mixed-chimeras recipients ( Fig. 5e and Supplementary Fig. 4a,c) , a result not replicated in the steady-state in 4-1BB-deficient mice (Fig. 2c) . This shows that expression of 4-1BBL on CLPs (Fig. 1) or their progeny can become active and suppressive for B cell development in conditions of considerable lymphopoiesis.
Expression of 4-1BB on wild-type bone marrow cells did not compensate for the lack of 4-1BB on the knockout cells in the mixed chimeras. This finding suggested that 4-1BB-4-1BBL interactions are cell intrinsic to differentiating myeloid progenitors and that 4-1BB-expressing T cells and NK cells resident in the bone marrow are unlikely to be the chief mediators of regulation. Extending that idea, we found that Tnfrsf9 -/-CMPs, separated from CLPs and HSCs, still showed enhanced differentiation into the myeloid lineage relative to wild-type CMPs when transferred into a T cell-deficient Rag1 -/-environment (Fig. 5f) .
Suppression of myelopoiesis and DC development by 4-1BBL
To confirm that the suppressive function of 4-1BB in myelopoiesis and DC development was due to the interaction with 4-1BBL, and to further support the idea that any interaction might be cell intrinsic in responding and differentiating progenitor cells, we generated mixed chimeras with bone marrow from Tnfsf9 -/-mice. Replicating the results with Tnfrsf9 -/-bone marrow, approximately 70% of DCs in the spleen, of both the conventional and plasmacytoid lineage, were derived from Tnfsf9 -/-bone marrow (Fig. 6a and Supplementary Fig. 4d) . Similarly, approximately five times as many cDCs in the lymph nodes were of Tnfsf9 -/-origin (Fig. 6b) . Moreover, a greater proportion of CD11b + Gr-1 + cells of Tnfsf9 -/-origin was present in the bone marrow (Fig. 6c) . T cell numbers were similar; however, again we found enhanced development of B cells from Tnfsf9 -/-bone marrow (Fig. 6a) . Collectively, these results show that in conditions of considerable hematopoiesis, the interaction of 4-1BB with 4-1BBL negatively regulates myelopoiesis and B lymphopoiesis in the bone marrow and the development of DCs and B cells that populate peripheral lymphoid organs.
Regulation of the development of lung DCs by 4-1BB
DCs also reside in many nonlymphoid tissues, such as the lung, liver, gut, kidney and skin 30, 31 , and such DCs have been proposed to arise peripherally from monocytes under the directive influence of inflammatory cytokines such as TNF and GM-CSF 32, 33 . In particular, the lung has DCs of both the conventional and plasmacytoid lineage that regulate pulmonary inflammation 34, 35 . Notably, approximately 95% of cDCs (CD11c hi I-A/I-E hi ) and 80% of pDCs (CD11c lo B220 + PDCA-1 + ) in the lungs of mixed wild-type and Tnfrsf9 -/-bone marrow chimeras developed from Tnfrsf9 -/-bone marrow (Fig. 7a,b) , in addition to many granulocytes (Fig. 7b) . The lung cDCs had an immature phenotype (CD80 lo CD86 lo CD40 lo I-A/I-E hi ) regardless of origin, although lung cDCs had low expression of both 4-1BB and 4-1BBL that was not present on splenic cDCs (Fig. 7c , and data not shown). These results suggest that 4-1BB and 4-1BBL might also limit peripheral DC development, such as from monocytes in the lung, as well as regulating myeloid progenitor development in the bone marrow.
The 4-1BB-4-1BBL interaction limits DC differentiation
We then stimulated wild-type or Tnfrsf9 -/-bone marrow cells with GM-CSF in vitro 32 . This culture system has been proposed to resemble the peripheral differentiation of monocytes into DCs, with bone marrow progenitors transitioning from a CD11b -CD11c -phenotype into a CD11b + CD11c -monocyte-like population before expressing CD11c 32, 36 . We induced 4-1BBL on a proportion of CD11c -and CD11c + cells at day 2 and found that expression continued through to day 6 (Fig. 8a) . Again, we easily detected 4-1BBL only when 4-1BB was not available for binding, which provided evidence of active engagement. No 4-1BB could be visualized on day 2, but it was considerably upregulated by day 4 and was retained through to day 6 on a small proportion of CD11c -cells and a large proportion of CD11c + cells. In support of the proposal of an active regulatory function, more CD11c hi bone marrow-derived DCs were generated over time from Tnfrsf9 -/-bone marrow (Fig. 8b) . The absence of 4-1BB again had no effect on maturation (data not shown). Thus, both 4-1BB and 4-1BBL are expressed during the differentiation of bone marrow-derived DCs and their interaction limits DC differentiation or outgrowth. Finally, we sorted myeloid progenitors from bone marrow and stimulated them with GM-CSF 37 . Myeloid progenitors (CD11b -CD11c -) differentiated into a monocyte-like phenotype (CD11b + CD11c -) and then into DCs (CD11b + CD11c + I-A/I-E hi ) and expressed both 4-1BB and 4-1BBL, similar to cultures of unseparated bone marrow cells ( Supplementary Fig. 5 online and data not shown). Again, the accumulation of DCs was greater at day 7 in Tnfrsf9 -/-myeloid progenitor cultures than in wild-type control cultures (Fig. 8c) . Notably, crosslinking 4-1BBL with plate-bound 4-1BB-Ig resulted in less accumulation of DCs from Tnfrsf9 -/-myeloid progenitors to numbers obtained with wild-type myeloid progenitor cultures (Fig. 8c) . Soluble 4-1BB-Ig, which cannot crosslink 4-1BBL, showed no substantial effect. These data confirm a suppressive function for 4-1BBL in controlling DC differentiation.
To further define the mechanism by which 4-1BBL is inhibitory, we tested whether the ligation of 4-1BBL by 4-1BB-Ig suppressed intracellular signaling in bone marrow cells differentiating into DCs. Plate-bound 4-1BB-Ig inhibited phosphorylation of the kinase Erk and the inhibitor IkBa ( Supplementary Fig. 6a online) . Casein kinase I is the only kinase reported to be activated by 4-1BBL 27 , but we found that an inhibitor of this molecule did not reverse suppression mediated by 4-1BB-Ig in myeloid-lineage and DC differentiation ( Supplementary Fig. 6b,c) . Published work has additionally reported that 4-1BBL's control of osteoclast development from bone marrow macrophages involves the production of IL-10 and interferon-b 28, 38 . However, we also failed to alter inhibition through crosslinkage 4-1BBL on myeloid progenitors by blocking those cytokines or transforming growth factor-b ( Supplementary Fig. 6d ,e).
DISCUSSION
Here we have shown that 4-1BBL was expressed on common myeloid and granulocyte-macrophage progenitor cells that are fundamental to myelopoiesis and that 4-1BB could be induced on many subsets of differentiating myeloid-lineage cells. The interaction of 4-1BB with 4-1BBL negatively regulated the development of myeloid-lineage cells from CMPs and GMPs and limited the differentiation of both conventional and plasmacytoid lineages of DCs. We also found that 4-1BBL was expressed on common lymphoid progenitors and suppressed development of B cells in conditions of considerable lymphopoiesis. Collectively, our results demonstrate an unappreciated function for these TNF 'superfamily' molecules in controlling highly organized pathways of cellular development and provide new insight into the control of distinct lineages of immune cells.
Although 4-1BBL was ubiquitously expressed on HSCs, the finding that steady-state numbers of these cells and MPPs were not substantially altered in 4-1BB-or 4-1BBL-deficient mice suggested that 4-1BBL is not normally active on HSCs. In contrast, steady-state numbers of GMPs and CD11b + myeloid-lineage cells were higher in situ in the absence of 4-1BB and 4-1BBL. Additionally, in vitro and in vivo studies with total myeloid progenitors, or purified CMPs, still showed the suppressive influence of 4-1BBL on myelopoiesis. Thus, we conclude that 4-1BB-4-1BBL interactions regulate the early steps of myelopoiesis, targeting CMPs or GMPs and/or cells undergoing transition from those cells into myeloidlineage cells. However, 4-1BBL expression on HSCs might still be relevant in certain inflammatory conditions, a subject that awaits future study.
Notably, when we 'mimicked' the 4-1BB binding to 4-1BBL by providing 4-1BB-Ig in a form that crosslinked 4-1BBL, this interaction suppressed the enhanced accumulation of Tnfrsf9 -/-myeloidlineage cells and DCs derived from unseparated bone marrow cells or from purified myeloid progenitors. In contrast, ligation of 4-1BB with an agonist antibody had no effect. Thus, 'reverse signaling' through 4-1BBL is responsible for regulation, providing data complementary to other reports describing a similar phenomenon through 4-1BBL, in which there is impeded proliferation of activated T cells and bone marrow macrophages differentiating into osteoclasts 8, 27, 28, 39 . We confirmed suppressive signaling by showing inhibition of activation of the growth-promoting NF-kB and Erk intracellular pathways in bone marrow cells differentiating into DCs. However, the nature of the intracellular signals transmitted through 4-1BBL that lead to less myelopoiesis is not clear and will need further analysis.
Unlike 4-1BBL that is detected in the bone marrow in situ, 4-1BB was highly regulated on progenitor cells, possibly because in this scenario 4-1BB functions as a typical ligand rather than a signaling receptor, fitting with the idea that its expression might be a ratelimiting factor for myelopoiesis. We found 4-1BB transiently on Lin -c-Kit hi differentiating mast cell precursors and also on differentiating myeloid-lineage cells (Lin + c-Kit int ), and its expression depended on GM-CSF. Similarly, GM-CSF alone promoted 4-1BB in myeloid progenitors differentiating into DCs. Thus, it is likely that this sophisticated and transient regulation might explain why 4-1BB was not detected on bone marrow progenitor cells immediately after isolation.
Our results obtained with differentiating myeloid-lineage cells and DCs derived from unseparated bone marrow cells or purified myeloid progenitors suggested that both 4-1BB and 4-1BBL can be expressed by these lineages, either separately or together, which led to the idea of cell-intrinsic regulation and/or crosstalk between the same or alternative stages of cells. The spatiotemporal interactions between 4-1BB and 4-1BBL in the bone marrow might therefore be very complex. Although 4-1BBL seems to be readily available, 4-1BB could be delivered by many subpopulations of cells, either on neighboring cells perhaps in specialized niches or on the same cell in a cell-intrinsic Figure 8 Interactions between 4-1BB and way. We found that the augmented outgrowth of Tnfrsf9 -/-myeloidlineage cells paralleled that of Tnfsf9 -/-myeloid-lineage cells in mixed-bone marrow chimeras in which wild-type cells (that could express either molecule) were also responding, which supported the idea of cell-intrinsic regulation. Furthermore, as total myeloid progenitors or purified CMPs from Tnfrsf9 -/-mice still showed enhanced myeloid-lineage and DC differentiation in vitro and in vivo, these results also favor the idea that differentiating myeloid-lineage and mast cell precursors are the main source of 4-1BB in the bone marrow. However, it is still possible that 4-1BB on resident or recirculating mature T cells and NK cells might modulate myelopoiesis, especially in some inflammatory conditions. We focused on DCs, as these cells are thought to develop mainly in the myeloid-lineage 30, 32, 40 . DC development is complex and not fully understood. Studies have identified a clonogenic progenitor, called a 'macrophage-DC progenitor' (Lin -CX3CR1 + c-Kit + ) 41 , that is a subset of the GMP population (on the basis of its phenotype of CD34 + FcgRII/III hi ) and gives rise to monocytes, macrophages and cDCs. Further data have shown that macrophage-DC progenitors can generate cDCs that reside in the spleen without transitioning through a monocytic intermediate 42 , whereas other reports have shown that cDCs in peripheral organs may derive from a monocyte precursor 32 . In contrast, neither macrophage-DC progenitors nor monocytes give rise to pDCs, which suggests that pDCs diverge from cDCs perhaps at the CMP or GMP stage 32, 40 . Furthermore, it has been proposed that Flt3 + cells in either the CMP or CLP population could develop into both cDCs and pDCs 40, 43 . In the absence of 4-1BB or 4-1BBL, we found more cDCs and pDCs in lymphoid and nonlymphoid organs, and more monocytes were generated in both bone marrow and blood. Also, we found enhanced B cell development in the bone marrow chimeras. Collectively, these results further support the conclusion that main regulation of myelopoiesis (and B lymphopoiesis) by 4-1BBL occurs in the bone marrow at the CMP or GMP stage, or in precursors of B lineage cells, including CLPs.
Peripheral tissue DCs might derive from separate DC precursors that seed these organs before being committed to final differentiation into mature DCs 32, 40 . Monocytes can be DC precursors and are suggested to give rise to cDCs in nonlymphoid organs 42, 44, 45 . It is not clear how this process is regulated, but the cytokine milieu, and specifically GM-CSF, might be crucial for monocyte differentiation 32, 33 . GM-CSF-induced bone marrow cultures are thought to mimic the stages of in vivo peripheral tissue DC differentiation 36, 46 . We found that 4-1BB and 4-1BBL were expressed during GM-CSFdriven differentiation and that their interaction limited the accumulation of bone marrow-derived DCs. Moreover, most cDCs in the lung of bone marrow chimeras originated from the Tnfrsf9 -/-population. That result might be related in part to the greater number of blood monocytes. However, the relative skewing of lung cDCs in favor of populations derived from Tnfrsf9 -/-cells was far greater than that of blood monocytes. Therefore, we suggest that 4-1BB and 4-1BBL could also participate in limiting more distal steps of cDC differentiation that potentially occur in the peripheral organ itself.
In conclusion, we have demonstrated a previously unrecognized function for 4-1BB and 4-1BBL in myelopoiesis and the development of DCs. Our work here complements published studies of other TNF 'superfamily' members showing that CD27 is expressed on HSCs and progenitor cells and that the binding of CD70 negatively regulates the myeloid colony-forming potential in vitro and B lymphopoiesis in vivo 47, 48 , and that the lymphotoxin-b receptor is expressed on mature DCs and contributes to the balance among peripheral lineages through binding lymphotoxin- a 1 b 2 (ref. 49) . Thus, the TNF 'superfamily' controls not only the responsiveness of mature lymphoid populations but also the balance among separate cell lineages.
METHODS
Mice. Tnfrsf9 -/-mice and Tnfsf9 -/-mice on a C57BL/6 background were bred at the La Jolla Institute for Allergy and Immunology and Emory University, respectively. C57BL/6J (CD45.2 + ), C57BL/6 Pep3b/BoyJ (CD45.1 + ) and Rag1 -/-mice were from the Jackson Laboratories. All experiments were in compliance with the regulations of the La Jolla Institute for Allergy and Immunology animal care committee in accordance with guidelines of the Association for the Assessment and Accreditation of Laboratory Animal Care. Studies with Tnfsf9 -/-bone marrow cells were done at Emory University.
Cell suspensions. Spleens and lymph nodes and lung tissue were digested for 30 min at 37 1C with collagenase D (Roche) and DNase I (Sigma-Aldrich). Bone marrow was extracted from the tibia and femur in HEPES-buffered (pH 7.4) RPMI-1640 medium (Invitrogen) containing 1% (vol/vol) FBS (Omega Scientific), and erythrocytes were lysed with red blood cell lysing buffer (Sigma-Aldrich). Lung cells underwent density-gradient centrifugation (density, 1.0875 ± 0.0010 g/cm 3 ) with Lympholyte-M (Cedarlane) for the separation of live cells from dead cells and red blood cells.
